{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:45:03Z","timestamp":1792100703223,"version":"4.4.0"},"reference-count":113,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2021,3,2]]},"DOI":"10.1001\/jama.2020.22532","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T11:35:35Z","timestamp":1614684935000},"page":"865","source":"Crossref","is-referenced-by-count":353,"title":["Diagnosis and Treatment of Irritable Bowel Syndrome"],"prefix":"10.1001","volume":"325","author":[{"given":"Michael","family":"Camilleri","sequence":"first","affiliation":[{"name":"Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"jrv200018r1","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders.","volume":"150","author":"Mearin","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"jrv200018r2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study.","volume":"160","author":"Sperber","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"jrv200018r3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1053\/j.gastro.2018.08.063","article-title":"Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018.","volume":"156","author":"Peery","year":"2019","journal-title":"Gastroenterology"},{"issue":"10","key":"jrv200018r4","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S2468-1253(20)30217-X","article-title":"Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis.","volume":"5","author":"Oka","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"jrv200018r5","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/BF01303162","article-title":"US householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact.","volume":"38","author":"Drossman","year":"1993","journal-title":"Dig Dis Sci"},{"issue":"17","key":"jrv200018r6","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1056\/NEJMra1207068","article-title":"Peripheral mechanisms in irritable bowel syndrome.","volume":"367","author":"Camilleri","year":"2012","journal-title":"N Engl J Med"},{"issue":"11","key":"jrv200018r7","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1111\/apt.2006.23.issue-11","article-title":"Determinants of healthcare-seeking behaviour among subjects with irritable bowel syndrome.","volume":"23","author":"Williams","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"jrv200018r8","first-page":"92","article-title":"Irritable bowel syndrome (guidelines for the diagnosis).","volume":"2","author":"Thompson","year":"1989","journal-title":"Gastroenterol Int."},{"key":"jrv200018r9","doi-asserted-by":"crossref","first-page":"II43","DOI":"10.1136\/gut.45.2008.ii43","article-title":"Functional bowel disorders and functional abdominal pain.","volume":"45","author":"Thompson","year":"1999","journal-title":"Gut"},{"issue":"5","key":"jrv200018r10","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders.","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"issue":"6","key":"jrv200018r11","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders.","volume":"150","author":"Lacy","year":"2016","journal-title":"Gastroenterology"},{"issue":"11","key":"jrv200018r12","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13957","article-title":"Irritable bowel syndrome: straightening the road from the Rome criteria.","volume":"32","author":"Camilleri","year":"2020","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"jrv200018r13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.cgh.2019.10.004","article-title":"Benefits and pitfalls of change from Rome III to Rome IV criteria for irritable bowel syndrome and fecal incontinence.","volume":"18","author":"Lin","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"jrv200018r14","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/ajg.2016.308","article-title":"Enhancing diagnostic performance of symptom-based criteria for irritable bowel syndrome by additional history and limited diagnostic evaluation.","volume":"111","author":"Sood","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"jrv200018r15","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3322\/caac.21457","article-title":"Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.","volume":"68","author":"Wolf","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"23","key":"jrv200018r16","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1001\/jama.2016.3332","article-title":"Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force.","volume":"315","author":"Lin","year":"2016","journal-title":"JAMA"},{"issue":"23","key":"jrv200018r17","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1001\/jama.2016.6828","article-title":"Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US Preventive Services Task Force.","volume":"315","author":"Knudsen","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"jrv200018r18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/nmo.2005.17.issue-1","article-title":"Overlap of gastrointestinal symptom complexes in a US community.","volume":"17","author":"Locke","year":"2005","journal-title":"Neurogastroenterol Motil"},{"issue":"3","key":"jrv200018r19","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1053\/j.gastro.2007.06.010","article-title":"Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study.","volume":"133","author":"Halder","year":"2007","journal-title":"Gastroenterology"},{"issue":"5","key":"jrv200018r20","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1053\/j.gastro.2019.12.021","article-title":"Prevalence of Rome IV functional bowel disorders among adults in the United States, Canada, and the United Kingdom.","volume":"158","author":"Palsson","year":"2020","journal-title":"Gastroenterology"},{"issue":"2","key":"jrv200018r21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cgh.2019.08.020","article-title":"Similarities in clinical and psychosocial characteristics of functional diarrhea and irritable bowel syndrome with diarrhea.","volume":"18","author":"Singh","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"jrv200018r22","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/j.cgh.2019.11.049","article-title":"Pretest and posttest probabilities of diagnoses of rectal evacuation disorders based on symptoms, rectal exam, and basic tests: a systematic review.","volume":"18","author":"Brandler","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"jrv200018r23","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.cgh.2010.06.031","article-title":"Digital rectal examination is a useful tool for identifying patients with dyssynergia.","volume":"8","author":"Tantiphlachiva","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"14","key":"jrv200018r24","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1056\/NEJMra020995","article-title":"Chronic constipation.","volume":"349","author":"Lembo","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"jrv200018r25","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13510","article-title":"Audit of the diagnosis of rectal evacuation disorders in chronic constipation.","volume":"31","author":"Chedid","year":"2019","journal-title":"Neurogastroenterol Motil"},{"issue":"7","key":"jrv200018r26","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13845","article-title":"Clinical presentation and characteristics of pelvic floor myofascial pain in patients presenting with constipation.","volume":"32","author":"Liu","year":"2020","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"jrv200018r27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/ajg.2016.466","article-title":"Screening for celiac disease in irritable bowel syndrome: an updated systematic review and meta-analysis.","volume":"112","author":"Irvine","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"jrv200018r28","article-title":"Development of a score to predict positive colonic histology in chronic diarrhea assessed in open-access colonoscopy.","author":"Atieh","journal-title":"J Clin Gastroenterol"},{"issue":"7","key":"jrv200018r29","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.14309\/ajg.0000000000000637","article-title":"Fecal bile acid testing in assessing patients with chronic unexplained diarrhea: implications for healthcare utilization.","volume":"115","author":"Vijayvargiya","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"jrv200018r30","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1136\/gutjnl-2019-320325","article-title":"Actionable biomarkers: the key to resolving disorders of gastrointestinal function.","volume":"69","author":"Camilleri","year":"2020","journal-title":"Gut"},{"issue":"4","key":"jrv200018r31","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/ajg.2010.55","article-title":"The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial.","volume":"105","author":"Chey","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"jrv200018r32","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2016.36","article-title":"Colorectal cancer in African Americans: an update.","volume":"7","author":"Williams","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"issue":"7","key":"jrv200018r33","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.cgh.2019.12.007","article-title":"Improving patient-provider relationships to improve health care.","volume":"18","author":"Drossman","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"jrv200018r34","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/ajg.2010.480","article-title":"Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial.","volume":"106","author":"Johannesson","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"jrv200018r35","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3748\/wjg.v21.i2.600","article-title":"Intervention to increase physical activity in irritable bowel syndrome shows long-term positive effects.","volume":"21","author":"Johannesson","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"2","key":"jrv200018r36","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1080\/13548506.2015.1051557","article-title":"Self-regulation evaluation of therapeutic yoga and walking for patients with irritable bowel syndrome: a pilot study.","volume":"21","author":"Shahabi","year":"2016","journal-title":"Psychol Health Med"},{"issue":"7","key":"jrv200018r37","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.cgh.2008.02.060","article-title":"Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome.","volume":"6","author":"Camilleri","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"jrv200018r38","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1053\/j.gastro.2016.02.034","article-title":"Centrally mediated disorders of gastrointestinal pain.","volume":"150","author":"Keefer","year":"2016","journal-title":"Gastroenterology"},{"issue":"4","key":"jrv200018r39","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1053\/j.gastro.2017.11.279","article-title":"Neuromodulators for functional gastrointestinal disorders (disorders of gut-brain interaction): a Rome Foundation working team report.","volume":"154","author":"Drossman","year":"2018","journal-title":"Gastroenterology"},{"issue":"8","key":"jrv200018r40","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1136\/gutjnl-2016-312230","article-title":"Plausibility criteria for putative pathophysiological mechanisms in functional gastrointestinal disorders: a consensus of experts.","volume":"67","author":"Tack","year":"2018","journal-title":"Gut"},{"issue":"1","key":"jrv200018r41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/0016-5085(87)90837-7","article-title":"Simplified assessment of segmental colonic transit.","volume":"92","author":"Metcalf","year":"1987","journal-title":"Gastroenterology"},{"issue":"5","key":"jrv200018r42","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/ajg.2012.5","article-title":"Colonic transit time and IBS symptoms: what\u2019s the link?","volume":"107","author":"T\u00f6rnblom","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"jrv200018r43","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1053\/j.gastro.2019.04.019","article-title":"Cumulative effects of psychologic distress, visceral hypersensitivity, and abnormal transit on patient-reported outcomes in irritable bowel syndrome.","volume":"157","author":"Simr\u00e9n","year":"2019","journal-title":"Gastroenterology"},{"issue":"3","key":"jrv200018r44","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/nmo.2010.22.issue-3","article-title":"Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort.","volume":"22","author":"Manabe","year":"2010","journal-title":"Neurogastroenterol Motil"},{"issue":"8","key":"jrv200018r45","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1136\/gutjnl-2011-301181","article-title":"Regional colon transit in patients with dys-synergic defaecation or slow transit in patients with constipation.","volume":"61","author":"Nullens","year":"2012","journal-title":"Gut"},{"issue":"8","key":"jrv200018r46","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/nmo.2010.22.issue-8","article-title":"Wireless pH-motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation.","volume":"22","author":"Camilleri","year":"2010","journal-title":"Neurogastroenterol Motil"},{"issue":"5","key":"jrv200018r47","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nrgastro.2018.27","article-title":"Expert consensus document: advances in the evaluation of anorectal function.","volume":"15","author":"Carrington","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"jrv200018r48","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.cgh.2016.11.013","article-title":"Rectal gas volume measured by computerized tomography identifies evacuation disorders in patients with constipation.","volume":"15","author":"Park","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"jrv200018r49","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13044","article-title":"Rectal gas volume: defining cut-offs for screening for evacuation disorders in patients with constipation.","volume":"29","author":"Park","year":"2017","journal-title":"Neurogastroenterol Motil"},{"issue":"4","key":"jrv200018r50","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/ajg.2010.54","article-title":"Prolonged balloon expulsion is predictive of abdominal distension in bloating.","volume":"105","author":"Shim","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"jrv200018r51","doi-asserted-by":"publisher","first-page":"519","DOI":"10.14309\/ajg.0000000000000149","article-title":"Colonic stool burden a useful surrogate for slow transit constipation as determined by a radiopaque transit study.","volume":"114","author":"Cangemi","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"16","key":"jrv200018r53","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1001\/jama.2019.14740","article-title":"Clinical approach to lactose intolerance.","volume":"322","author":"Micic","year":"2019","journal-title":"JAMA"},{"issue":"10","key":"jrv200018r54","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.cgh.2018.01.047","article-title":"Increased prevalence of rare sucrase-isomaltase pathogenic variants in irritable bowel syndrome patients.","volume":"16","author":"Garcia-Etxebarria","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"jrv200018r55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM199507063330101","article-title":"A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance.","volume":"333","author":"Suarez","year":"1995","journal-title":"N Engl J Med"},{"issue":"12","key":"jrv200018r56","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1136\/gutjnl-2015-309889","article-title":"Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis.","volume":"65","author":"Valentin","year":"2016","journal-title":"Gut"},{"issue":"5","key":"jrv200018r57","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1053\/j.gastro.2018.11.069","article-title":"Commentary: current practice in the diagnosis of bile acid diarrhea.","volume":"156","author":"Vijayvargiya","year":"2019","journal-title":"Gastroenterology"},{"issue":"3","key":"jrv200018r58","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/MOG.0000000000000348","article-title":"Small intestinal bacterial overgrowth as a cause for irritable bowel syndrome: guilty or not guilty?","volume":"33","author":"Aziz","year":"2017","journal-title":"Curr Opin Gastroenterol"},{"issue":"2","key":"jrv200018r59","doi-asserted-by":"publisher","first-page":"165","DOI":"10.14309\/ajg.0000000000000501","article-title":"ACG clinical guideline: small intestinal bacterial overgrowth.","volume":"115","author":"Pimentel","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"jrv200018r60","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1136\/gut.2009.205476","article-title":"Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS.","volume":"60","author":"Yu","year":"2011","journal-title":"Gut"},{"issue":"6","key":"jrv200018r61","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1136\/gut.2006.108712","article-title":"Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.","volume":"56","author":"Posserud","year":"2007","journal-title":"Gut"},{"issue":"1","key":"jrv200018r62","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1004409","article-title":"Rifaximin therapy for patients with irritable bowel syndrome without constipation.","volume":"364","author":"Pimentel","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"jrv200018r63","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cgh.2006.12.023","article-title":"Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation.","volume":"5","author":"Rao","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"jrv200018r64","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s10350-006-0814-9","article-title":"Randomized, controlled trial shows biofeedback to be superior to alternative treatments for patients with pelvic floor dyssynergia-type constipation.","volume":"50","author":"Heymen","year":"2007","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"jrv200018r65","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/ajg.2010.53","article-title":"Long-term efficacy of biofeedback therapy for dyssynergic defecation: randomized controlled trial.","volume":"105","author":"Rao","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"jrv200018r66","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1053\/j.gastro.2009.12.040","article-title":"Biofeedback is superior to electrogalvanic stimulation and massage for treatment of levator ani syndrome.","volume":"138","author":"Chiarioni","year":"2010","journal-title":"Gastroenterology"},{"issue":"1","key":"jrv200018r67","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00384-008-0567-0","article-title":"Comparative study between biofeedback retraining and botulinum neurotoxin in the treatment of anismus patients.","volume":"24","author":"Farid","year":"2009","journal-title":"Int J Colorectal Dis"},{"issue":"13","key":"jrv200018r68","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1016\/j.cgh.2020.02.027","article-title":"Effects of colesevelam on bowel symptoms, biomarkers, and colonic mucosal gene expression in patients with bile acid diarrhea in a randomized trial.","volume":"18","author":"Vijayvargiya","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"jrv200018r69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41395-018-0084-x","article-title":"American College of Gastroenterology monograph on management of irritable bowel syndrome.","volume":"113","author":"Ford","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"jrv200018r70","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S2468-1253(19)30324-3","article-title":"Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis.","volume":"5","author":"Black","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"jrv200018r71","doi-asserted-by":"publisher","first-page":"b3154","DOI":"10.1136\/bmj.b3154","article-title":"Soluble or insoluble fibre in irritable bowel syndrome in primary care? randomised placebo controlled trial.","volume":"339","author":"Bijkerk","year":"2009","journal-title":"BMJ"},{"issue":"5","key":"jrv200018r73","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/apt.15419","article-title":"Review article: biological mechanisms for symptom causation by individual FODMAP subgroups\u2014the case for a more personalised approach to dietary restriction.","volume":"50","author":"Wang","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"jrv200018r74","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s10620-020-06623-6","article-title":"Small intestinal bacterial overgrowth syndrome: a guide for the appropriate use of breath testing.","volume":"66","author":"Massey","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"10","key":"jrv200018r75","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S2468-1253(17)30154-1","article-title":"Country, regional, and global estimates for lactose malabsorption in adults: a systematic review and meta-analysis.","volume":"2","author":"Storhaug","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"jrv200018r76","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1111\/apt.14065","article-title":"Systematic review: quality of trials on the symptomatic effects of the low FODMAP diet for irritable bowel syndrome.","volume":"45","author":"Krogsgaard","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"jrv200018r77","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41395-018-0222-5","article-title":"Effect of antidepressants and psychological therapies in irritable bowel syndrome: an updated systematic review and meta-analysis.","volume":"114","author":"Ford","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"jrv200018r78","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/apt.14840","article-title":"Systematic review with meta-analysis: online psychological interventions for mental and physical health outcomes in gastrointestinal disorders including irritable bowel syndrome and inflammatory bowel disease.","volume":"48","author":"Hanlon","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"jrv200018r79","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S2468-1253(19)30243-2","article-title":"Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial.","volume":"4","author":"Everitt","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"jrv200018r80","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s41395-018-0396-x","article-title":"Durability and decay of treatment benefit of cognitive behavioral therapy for irritable bowel syndrome: 12-month follow-up.","volume":"114","author":"Lackner","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"jrv200018r81","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/gutjnl-2020-321191","article-title":"Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis.","volume":"69","author":"Black","year":"2020","journal-title":"Gut"},{"key":"jrv200018r82","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7680963","article-title":"Acupuncture plus Chinese herbal medicine for irritable bowel syndrome with diarrhea: a systematic review and meta-analysis.","volume":"2019","author":"Yan","year":"2019","journal-title":"Evid Based Complement Alternat Med"},{"issue":"6","key":"jrv200018r83","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/ajg.2012.66","article-title":"Acupuncture for irritable bowel syndrome: systematic review and meta-analysis.","volume":"107","author":"Manheimer","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"jrv200018r84","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003460.pub2","article-title":"Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome.","author":"Quartero","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"jrv200018r85","doi-asserted-by":"publisher","first-page":"a2313","DOI":"10.1136\/bmj.a2313","article-title":"Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis.","volume":"337","author":"Ford","year":"2008","journal-title":"BMJ"},{"issue":"6","key":"jrv200018r86","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/MCG.0b013e3182a88357","article-title":"Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis.","volume":"48","author":"Khanna","year":"2014","journal-title":"J Clin Gastroenterol"},{"issue":"9","key":"jrv200018r87","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/ajg.2014.148","article-title":"Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis.","volume":"109","author":"Ford","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"jrv200018r88","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1136\/gutjnl-2018-318160","article-title":"Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis.","volume":"69","author":"Black","year":"2020","journal-title":"Gut"},{"issue":"5","key":"jrv200018r89","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cgh.2007.12.015","article-title":"Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.","volume":"6","author":"Andresen","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"jrv200018r90","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/apt.2015.41.issue-5","article-title":"Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome.","volume":"41","author":"Camilleri","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"jrv200018r91","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1136\/gutjnl-2013-305965","article-title":"Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS.","volume":"64","author":"Bajor","year":"2015","journal-title":"Gut"},{"issue":"1","key":"jrv200018r92","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/ajg.2011.355","article-title":"The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis.","volume":"107","author":"Menees","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"jrv200018r93","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/ajg.2013.197","article-title":"Randomized clinical trial: macrogol\/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome.","volume":"108","author":"Chapman","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"jrv200018r94","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/apt.2008.29.issue-3","article-title":"Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome\u2014results of two randomized, placebo-controlled studies.","volume":"29","author":"Drossman","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"jrv200018r95","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1365-2036.2011.04983.x","article-title":"Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation.","volume":"35","author":"Chey","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"jrv200018r96","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.cgh.2013.04.032","article-title":"Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis.","volume":"11","author":"Videlock","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"jrv200018r97","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S2468-1253(19)30246-8","article-title":"Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis.","volume":"4","author":"Luthra","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"jrv200018r98","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41395-018-0026-7","article-title":"Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials.","volume":"113","author":"Brenner","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"jrv200018r99","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1080\/03007995.2018.1430024","article-title":"Safety and tolerability of plecanatide in patients with chronic idiopathic constipation: long-term evidence from an open-label study.","volume":"34","author":"Barish","year":"2018","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"jrv200018r100","doi-asserted-by":"publisher","first-page":"281","DOI":"10.14309\/ajg.0000000000000516","article-title":"Efficacy of tenapanor in treating patients with irritable bowel syndrome with constipation: a 12-week, placebo-controlled phase 3 trial (T3MPO-1).","volume":"115","author":"Chey","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"jrv200018r101","article-title":"Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.","author":"Evans","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"jrv200018r102","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.cgh.2019.07.007","article-title":"Relative efficacy of tegaserod in a systematic review and network meta-analysis of licensed therapies for irritable bowel syndrome with constipation.","volume":"18","author":"Black","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"jrv200018r103","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S2468-1253(18)30123-7","article-title":"Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial.","volume":"3","author":"Nakajima","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"11","key":"jrv200018r104","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/jcm6110101","article-title":"Pharmacotherapy for irritable bowel syndrome.","volume":"6","author":"Camilleri","year":"2017","journal-title":"J Clin Med"},{"issue":"10","key":"jrv200018r105","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/apt.15001","article-title":"Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome.","volume":"48","author":"Ford","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"jrv200018r106","doi-asserted-by":"publisher","first-page":"S218","DOI":"10.1097\/MCG.0b013e31817fadd6","article-title":"Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: a multicenter, randomized study.","volume":"42","author":"Andriulli","year":"2008","journal-title":"J Clin Gastroenterol"},{"issue":"8","key":"jrv200018r107","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1177\/2050640619862721","article-title":"Efficacy and safety of Gelsectan for diarrhoea-predominant irritable bowel syndrome: a randomised, crossover clinical trial.","volume":"7","author":"Trifan","year":"2019","journal-title":"United European Gastroenterol J"},{"issue":"2","key":"jrv200018r108","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1053\/j.gastro.2017.05.003","article-title":"Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome.","volume":"153","author":"Pinto-Sanchez","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"jrv200018r109","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/j.gastro.2019.03.049","article-title":"Gut microbiota in patients with irritable bowel syndrome\u2014a systematic review.","volume":"157","author":"Pittayanon","year":"2019","journal-title":"Gastroenterology"},{"issue":"3","key":"jrv200018r110","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/apt.15330","article-title":"Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome.","volume":"50","author":"Ianiro","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"jrv200018r111","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/gutjnl-2019-319630","article-title":"Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study.","volume":"69","author":"El-Salhy","year":"2020","journal-title":"Gut"},{"issue":"21","key":"jrv200018r112","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1056\/NEJMe1913807","article-title":"Fecal microbiota transplantation for dysbiosis\u2014predictable risks.","volume":"381","author":"Blaser","year":"2019","journal-title":"N Engl J Med"},{"key":"jrv200018r52","unstructured":"Lactose intolerance. MedlinePlus. Updated August 18, 2020. Accessed October 23, 2020. https:\/\/medlineplus.gov\/genetics\/condition\/lactose-intolerance"},{"key":"jrv200018r72","unstructured":"National Institute for Health and Care Excellence. Addendum to NICE guideline CG61, irritable bowel syndrome in adults: diagnosis and management of irritable bowel syndrome in primary care. February 2015. Accessed October 23, 2020. https:\/\/www.nice.org.uk\/guidance\/cg61\/evidence\/addendum-pdf-7081259797?"},{"key":"jrv200018r113","unstructured":"Fecal microbiota for transplantation: safety alert\u2014risk of serious adverse events likely due to transmission of pathogenic organisms. US Food and Drug Administration. Posted March 12, 2020. Updated April 7, 2020. Accessed October 23, 2020. https:\/\/www.fda.gov\/safety\/medical-product-safety-information\/fecaFl-microbiota-transplantation-safety-alert-risk-serious-adverse-events-likely-due-transmission?"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2776885\/jama_camilleri_2021_rv_200018_1618509307.93133.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:11:32Z","timestamp":1618963892000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2776885"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2021,3,2]]},"references-count":113,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,3,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2020.22532","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,2]]}}}